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Hippocampal tau oligomerization early in
tau pathology coincides with a transient
alteration of mitochondrial homeostasis
and DNA repair in a mouse model of
tauopathy
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Deborah L. Croteau3, Marie-Christine Galas2† and Vilhelm A. Bohr1,3*†
Abstract
Insoluble intracellular aggregation of tau proteins into filaments and neurodegeneration are histopathological
hallmarks of Alzheimer disease (AD) and other tauopathies. Recently, prefibrillar, soluble, oligomeric tau
intermediates have emerged as relevant pathological tau species; however, the molecular mechanisms of neuronal
responses to tau oligomers are not fully understood. Here, we show that hippocampal neurons in six-month-old
transgenic mouse model of tauopathy, THY-Tau22, are enriched with oligomeric tau, contain elongated
mitochondria, and display cellular stress, but no overt cytotoxicity compared to the control mice. The levels of
several key mitochondrial proteins were markedly different between the THY-Tau22 and control mice hippocampi
including the mitochondrial SIRT3, PINK1, ANT1 and the fission protein DRP1. DNA base excision repair (BER) is the
primary defense system against oxidative DNA damage and it was elevated in six-month-old transgenic mice. DNA
polymerase β, the key BER DNA polymerase, was enriched in the cytoplasm of hippocampal neurons in six-month-
old transgenic mice and localized with and within mitochondria. Polβ also co-localized with mitochondria in
human AD brains in neurons containing oligomeric tau. Most of these altered mitochondrial and DNA repair events
were specific to the transgenic mice at 6 months of age and were not different from control mice at 12 months of
age when tau pathology reaches its maximum and oligomeric forms of tau are no longer detectable. In summary,
our data suggests that we have identified key cellular stress responses at early stages of tau pathology to preserve
neuronal integrity and to promote survival. To our knowledge, this work provides the first description of multiple
stress responses involving mitochondrial homeostasis and BER early during the progression of tau pathology, and
represents an important advance in the etiopathogenesis of tauopathies.
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Introduction
The pathological aggregation of the microtubule-
associated protein tau into filaments is a histopatho-
logical hallmark of a number of neurodegenerative
diseases collectively known as tauopathies, including
Alzheimer disease (AD) [5, 85]. Substantial evidence
suggests that the impairment of neuronal function de-
velops before the formation of detectable levels of in-
soluble tangles in tauopathy mouse models [89], and
that soluble oligomeric tau intermediates, formed
early during the process of tau aggregation, might be
the more pathological forms of tau [38, 46, 64].
In AD brain, neurons with tau aggregation, named
neurofibrillary tangles (NFTs), can survive for decades
despite progressive functional impairment [59]. This
suggests that neurons that develop tau pathology may
activate a response mechanism to maintain cell function
and to delay cell death. The molecular mechanism of
this putative cellular survival response remains largely
unknown.
Mitochondria are the primary organelles for the pro-
duction of the cellular energy substrate ATP. They also
play a central role in other key cellular processes includ-
ing cytosolic calcium buffering [23], and control of
apoptosis [19]. Mitochondrial dysfunction and defects
cause or are central pathological components of a num-
ber of neurodegenerative diseases [25, 92].
Mitochondrial abnormalities including aberrant mito-
chondrial morphology have been detected early in AD
patients and in experimental AD and tauopathy model
systems [75, 91]. Moreover, there is interplay between
mitochondrial dysfunction and tau pathology [25, 41,
57]. These observations suggest that interplay between
mitochondrial dysfunction and tau pathology may initi-
ate and drive the progression of tauopathies.
Mitochondrial DNA (mtDNA) is organized into
structures called nucleoids in close association with
the mitochondrial inner membrane [9]. Because the
mitochondrial inner membrane is a major site of
mitochondrial ROS production [10], mtDNA is ex-
pected to be constantly undergoing oxidative DNA
damage such as 8-oxoG. DNA base excision repair
(BER) is the prominent DNA repair pathway for the
repair of oxidative DNA lesions [2] and probably the
most important DNA repair pathway in human mito-
chondria [4, 78].
Recent reports have shown the presence of the major
nuclear BER DNA polymerase, DNA polymerase β
(Polβ), in mitochondria in the brain [65, 76], with a
likely role in mtDNA repair. 3xTgAD mice with a 50%
reduction of Polβ (3xTg AD/Polβ+/−), which also contain
a mutated version of human tau, display exacerbated AD
phenotypes with impaired cellular bioenergetics and
mitochondrial dysfunction [58, 77].
Collectively, these studies suggest that tau alterations,
mitochondrial abnormalities, and BER deficiencies may
interact with one another to modulate response and the
development of tauopathies; however, the timing and
role of these processes in the early stages of tauopathy is
largely unknown.
In this study, using THY-Tau22, a mouse model of
tauopathy, we show that early during tau pathology, hip-
pocampal neurons containing oligomerized tau proteins,
exhibit changes in mitochondrial structure, enhanced
DNA repair activity, and mitochondrial enrichment of
Polβ, but no overt cytotoxicity. These events were
mostly corrected to the level of wild-type littermate mice
at a later stage of tau pathology when tau oligomers are
no longer detectable. We conclude that early in the pro-
gression of tau pathology in hippocampal neurons when
prefibrillar tau oligomers are prominent, significant
changes in mitochondrial homeostasis and DNA repair
take place to counter cellular stress and to promote cell
survival.
Materials and methods
Animals
THY-Tau22 mouse (henceforth Tg), and its non-
transgenic littermates (Wt) have been described before
[70]. The Tg mouse was generated with a construct con-
taining human tau46 mutated at G272V and P301S posi-
tions and expressed under the control of Thy1.2
promoter. Tau pathology begins at 3 months of age in
the subiculum and CA1 subfield, two brain regions af-
fected early in human AD, spreading from there to the
hippocampal dentate gyrus and cortex in older animals
[82]. At 6 months of age, Tg mice start developing
spatial memory impairment and anxiety [47]. All Tg
mice used in the present study were heterozygous. Non-
transgenic Wt littermate mice were used as controls in
all experiments. Both the THY-Tau22 and wild type lit-
termate mice were generated from the same breeds. All
mice were on C57Bl6/J background. Because no gender
differences were observed in a previous report [47], data
from both males and females were analyzed as a single
group. In each experiment, three mice per category were
analyzed (6-mo Tg, 6-mo Wt, 12-mo Tg, 12-mo Wt).
All animals were kept in standard animal cages (12 h/12
h light/dark cycle, at 22 °C), with ad libitum access to
food and water. The animals were maintained in compli-
ance with institutional protocols (Comité d’éthique en
expérimentation animale du Nord Pas-de-Calais, no.
0508003). All of the animal experiments were performed
in compliance with and following the approval of the
local Animal Ethical Committee (agreement #12787–2,
015,101,320,441,671 v9 from CEEA75, Lille, France),
standards for the care and use of laboratory animals, and
the French and European Community rules.
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Immunofluorescence
Immunofluorescence was performed as described previ-
ously [84] using the following antibodies: TOC1 (a gen-
erous gift from Dr. Nicholas Kanaan) for prefibrillar tau
oligomers [64]; AT8 (Thermo Scientific) and Tau pT212
(Life Technologies) are phospho-dependent antibodies,
which are present from the early to late stages of tau
pathology; anti-8oxoG (Santa Cruz Biotechnology);
ANT1 (ab102032, Abcam); VDAC1 (ab14734, Abcam);
OGG1 (NB100–106, Novus); Polβ (ab26343, Abcam);
cleaved caspase 3 (9661 L, Cell Signaling Technology).
DAPI was used as a chromatin counterstain. Hippocam-
pal sections from Tg and Wt mice (n = 3 for each mouse
category) were acquired using an LSM 710 confocal
laser-scanning microscope (Carl Zeiss). The confocal
microscope was equipped with a 488-nm Argon laser,
561-nm diode-pumped solid-state laser, and a 405-nm
ultraviolet laser. The images were acquired using an oil
63X Plan-APOCHROMAT objective (1.4 NA). All re-
cordings were performed using the appropriate sampling
frequency (16 bits, 1024–1024 images, and a line average
of 4). Serial sections from the three-dimensional recon-
struction were acquired using Z-steps of 0.2 μm. For
each section, cellular and nuclear (based on DAPI detec-
tion) fluorescence of CA1 cells were quantified using the
FIDJI macro application of ImageJ (confocal microscopy
platform, IMPRT, Institut de Médecine Prédictive et de
Recherche Thérapeutique, Lille). Quantification corre-
sponds to the z stack of serial confocal sections covering
the entire thickness of the brain section. Cellular or nu-
clear fluorescence was quantified in CA1 sections from
three different Tg and three different Wt littermates
mice for each age (one section per mouse). The quantifi-
cation shows the mean of cellular or nuclear fluores-
cence values per mouse.
Cell density
Cell density was determined by counting the number of
nuclei (based on DAPI staining) per surface unit in CA1
sections. Sagittal CA1 sections from 6- and 12-mo Wt
and Tg mice hippocampi (n = 3 for each mouse cat-
egory) were incubated with a solution (2.5 μg/ml in PBS)
of 4′,6-diamidino-2-phenylindole (DAPI) (Thermo-
Fischer) for 10 min at room temperature, and mounted
with Vectashield/DAPI (Vector Laboratories). Nuclear
DAPI fluorescence was analyzed by LSC laser scanning
confocal microscopy (confocal microscopy platform,
IMPRT, Institut de Médecine Prédictive et de Recherche
Thérapeutique, Lille). Nuclei quantification corresponds
to the z stack of serial confocal sections covering the en-
tire thickness of the brain section. For each mouse cat-
egory, the quantification shows the mean of nuclei per
surface unit per mouse.
Transmission electron microscopy
Hippocampus from Tg and Wt mice (n = 3 for each cat-
egory) was fixed with paraformaldehyde 2%, picric acid
(1.3% saturated in H2O) 0.1%, glutaraldehyde 1% in 0.1
M phosphate buffer for 72 h at 4 °C. Tissues were rinsed
3 times in 0.1M phosphate buffer, post-fixed in 1% os-
mium tetroxide in 0.1M phosphate buffer for 1 h at
room temperature, then gradually dehydrated in ethanol,
and embedded in araldite (one block par hippocampus).
Thin sections (85 nm) were made with a ultracut (Leica
EM UC7), contrasted with uranyl acetate 2% and lead
citrate (Reynolds). Three sections per hippocampus, at
the CA1 level, were observed with Zeiss EM 900 micro-
scope and acquisition (100–200 images from different
planes for each section) realized with camera gatan
(Orius SC 1000). Mitochondrial area was quantified
using the FIDJI macro application of ImageJ (confocal
microscopy platform, IMPRT, Institut de Médecine Pré-
dictive et de Recherche Thérapeutique, Lille) in six rep-
resentative images from three different sections per
block. For each mouse category, the quantification
shows the mean of mitochondrial area per mouse.
Immunoelectron microscopy
Hippocampus from Tg and Wt mice (n = 3 for each cat-
egory) was fixed with 0.1% glutaraldehyde and 4% para-
formaldehyde in 0.1M Phosphate buffer for 24 h at 4 °C.
Tissues were then rinsed in 0.1M phosphate-buffer,
dehydrated in ethanol (30 and 50%, 10 min each) at 4 °C,
then 70 and 96% 10min each at − 20 °C, and embedded
in LRWhite resin (3 × 1 h − 20 °C, then overnight at
4 °C), and polymerized under UV for 3 days at 4 °C. Ul-
trathin sections (85 nm) were made with a ultracut
(Leica EM UC7). After 1 h saturation with 0.1M Tris,
150 mM NaCl in 1% BSA and 1% NGS1, immunolabel-
ing was carried out using Polβ antibody (ab26343,
Abcam). Polβ labeling was revealed with a goat anti-
rabbit IgG gold conjugate (18 nm in diameter) (Jackson
ImmunoResearch Laboratories). Staining of the ultrathin
sections was carried out using 2% uranyl acetate in 50%
ethanol. Labeling was observed under a Zeiss EM 900
electron microscope and acquisition realized with
Table 1 Braak stages, region, age, gender, and post mortem
interval of the brains used in the study
Braak stage Tissue Age Sex PMIa (hours)
Ctr#1 0 Frontal Cortex 72 F 72
Ctr#2 0 Frontal Cortex 47 M 39
Ctr#3 0 Frontal Cortex 74 M 48
AD#1 VI Frontal Cortex 73 F 5
AD#2 VI Frontal Cortex 76 F 22
AD#3 VI Frontal Cortex 78 M 17
aPMI post mortem interval
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camera gatan (Orius SC 1000). Three sections per
hippocampus, at the CA1 level, were observed with Zeiss
EM 900 microscope and acquisition (100–200 images
per section) realized with camera gatan (Orius SC 1000).
Human brains
Human brain samples were obtained from the Lille Neu-
robank, which was given to the French Research Ministry
by the Lille Regional Hospital (CHRU-Lille) on August 14,
2008 under the reference DC- 2000-642. The Lille Neuro-
bank fulfills criteria from the French Law on biological re-
sources, including informed consent, ethics review
committee, and data protection (article L1243–4 du Code
de la Santé publique, August 2007). Frontal cortex sec-
tions from human non-dement control (Ctr) and Braak VI
Alzheimer brains (AD) (n = 3 for each category) were used
for immunofluorescence analysis (Table 1).
Isolation of CA1 hippocampal region or whole
hippocampus from mouse brain tissues
Brain areas where tau pathology is localized in the Tg
mouse brain, i.e. the CA1 subfield of the hippocampus
in 6-month-old mice, or the whole hippocampus in 12-
month-old mice, were dissected, snap frozen in liquid
nitrogen, and stored at − 80 °C. For each region, analyses
were systematically compared between Tg and Wt mice
to highlight the effect of tau pathology.
The CA1 subfield of the hippocampus from Tg and
Wt littermates mice (n = 3 for each category) was iso-
lated from whole brain hemispheres. Coronal sections
(1 mm) from frozen mouse brain hemisphere were cut
using an acrylic mouse brain matrice and matrice blades.
For each frozen slice with hippocampus, the cortex was
removed and the CA1 region was dissected on ice using
a scalpel under a binocular loop (Leica MZ75) following
anatomical landmarks (Figure S10).
Protein extracts
Mouse brain samples were lysed for 30 min in ice-cold
RIPA buffer containing protease inhibitors and phos-
phatase inhibitors cocktails (Roche). Debris was removed
by centrifugation at 20,000 g at 4 °C for 10 min. The
supernatant was used for immunoblotting.
For BER assays, the brain samples were suspended in buf-
fer containing 20mM HEPES, pH 7.5, 50mM KCl, 2mM
EGTA and Complete protease inhibitor (Roche) and were
homogenized. Lysates were centrifuged at 800 g for 10min
and suspended (2mg/ml) in 20mM HEPES (pH 7.0), 150
mM KCl, 2mM EGTA, 1% (w/v) CHAPSO (Sigma), and
protease inhibitor mixture and incubated at 4 °C for 1 h
with end-over-end rotation. The lysates were centrifuged at
100,000 g for 1 h, and the supernatants were collected.
Western blot
Whole cell extracts were separated in Tris-glycine SDS
gels and transferred onto PVDF membrane. Each experi-
ment was done 3–5 times. The images are shown as three
technical replicates of one biological replicate. The pri-
mary antibodies used were: Actin (A5441, Sigma-Aldrich),
Ac-SOD2 (Lys122, ab214675, Abcam), Caspase-3 (9962,
Cell Signaling), DRP1 (8570, Cell Signaling), GAPDH
(sc25778, Santa Cruz Biotechnology), LC3 (NB600–1384,
Novus Biologicals), OGG1 (T1851, Epitomics), OPA1 (67,
589, Cell Signaling), PGC-1α (NBP1–04676, Novus Bio-
logicals), DRP1 (8570S, Cell Signaling), Phospho-DRP1
(Ser616, 3455, Cell Signaling), PINK1 (ab23707, Abcam),
Polβ (ABE1408, Millipore), SIRT3 (2627, Cell Signaling),
SOD2 (13,194, Cell Signaling), Tau (A002401–2, Agilent),
TFAM (H00007019-B01P, Abnova), VDAC1 (ab14734,
Abcam), and Vinculin (ab129002, To detect OXPHOS
complex assembly, we used an assembly-dependent total
OXPHOS rodent antibody cocktail (ab110413, Abcam).
The antibodies in the cocktail are against a subunit that is
labile when its complex is not assembled.
MtDNA copy number
Total DNA (i.e. nuclear and mitochondrial) was ex-
tracted from mice brain using QIAamp DNA mini kit
(Qiagen). The number of mtDNA molecules, or mtDNA
copy number, was determined by quantitative-PCR using
SYBR Green Supermix PCR (Bio-Rad), following the
manufacturer’s protocol, and StepOnePlus Real-Time
PCR system (Life Technologies). Nucleotide sequence of
the primers is provided in Fig.12S.
MtDNA integrity analysis
MtDNA integrity was analyzed using a PCR-based
method as described previously [3, 68, 92] Briefly, PCR
products were separated in agarose gel and the relative
intensity of the amplicons, reflecting the level of integrity
of the mtDNA templates, was measured using Image J.
The nucleotide sequence of the PCR primers are shown
in Fig. S12).
(See figure on previous page.)
Fig. 1 CA1 neurons in 6-mo Tg mice are enriched with tau oligomers. a Schematic of tau pathology progression in CA1 neurons of THY-Tau22
mice. b Representative images of sagittal CA1 sections from 6- and 12-mo Tg and Wt mice hippocampus (n = 3 for each mouse category). The
sections were labeled with antibodies against pathological phospho-tau (pThr212), and tau oligomers (TOC1), respectively. The sections were
analyzed by laser scanning confocal microscopy (z projection). Nuclei were visualized by DAPI staining. The scale bars represent 20 μm
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AP site incision assay
Oligonucleotide containing a synthetic analogue of an AP-
site 3-hydroxy-2- hydroxymethyltetrahydrofuran (shown
as X) was annealed to its complementary oligonucleotide.
The AP-site incision reaction was carried out in 20mM
HEPES-KOH pH 7.5, 50mM KCl, 5mM MgCl2, 1 mM
DTT, 0.36mg/ml BSA, 0.5% glycerol, using 1 μg extract
and 2 pmol DNA substrate, at 30 °C for 5min.
Polβ activity assay (gap filling assay)
The assay for Polβ activity was carried out as follows.
The extracts (5 μg) were incubated on ice for 5 min in
50mM HEPES-KOH pH 7.5, 5 mM MgCl2, 70 mM KCl,
1 mM DTT, 50 μM of each dNTP, 0.36 mg/ml BSA, and
0.6 mMN-ethylmaleimide (NEM), before adding DNA
substrate and initiation of DN synthesis. At the concen-
tration used here, NEM inhibits non-Polβ DNA poly-
merases [4]. Polβ dependent DNA synthesis reaction
was carried out at 37 °C for 10 min.
8-oxo-G excision assay
Reactions were carried out in 20mM Tris-HCl pH 7.5,
0.1M NaCl, 3 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA,
0.5% glycerol, using 10 μg extract, 1 pmol DNA sub-
strate, at 37 °C for 16 h.
Uracil excision assay
Reactions were carried out in 20mM Tris-HCl pH 7.5,
50 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA,
5 μg extract, and 5 pmol DNA substrate at 37 °C for 15
min. Reactions were stopped by adding 1M piperidine
and heated at 90 °C for 20 min to cleave AP site gener-
ated after uracil removal.
The nucleotide sequences of all the oligonucleotides
are shown in Fig. S12. DNA substrates were prepared by
annealing the complementary oligos in 100mM NaCl2,
and 10 mM Tris-HCl, 90 °C for 5 min and slowly cooled
to room temperature. All the reactions were terminated
by adding loading buffer (10 mM EDTA, 95% formam-
ide, 0.01% bromophenol blue, 0.01% xylene cyanol) and
heated at 95 °C for 5 min. The unrepaired substrates (S),
and the repair products (P) were separated by
electrophoresis in a 15% polyacrylamide gel (19:1 acryl-
amide:bis), and were visualized in Typhoon 9410 (Amer-
sham Biosciences), and quantified using Image J.
Statistics
Two-tailed, unpaired t-test was used for statistical ana-
lysis of WB, transmission electron microscopy, immuno-
fluorescence, BER activity and cell density (GraphPad
Prism 7). The normality of data was tested by Q-Q plot-
ting. For WB and BER activity, each lane represents one
biological replicate (i.e. one sample from one mouse),
and the number of biological replicates is indicated with
green and red dots on the graph. For transmission elec-
tron microscopy and immunofluorescence, each bio-
logical replicate corresponds to one mouse. The number
of biological replicates is indicated in the legends.
For cell density, each biological replicate corresponds
to one mouse. The number of biological replicates is in-
dicated with green and red dots on the graph. The ex-
perimenters were not blinded. Data are presented as
mean ± SEM, *P < 0.05; **P < 0.01; ***P < 0.001.
Results
Hippocampal neurons in six-month-old Tg mice are
enriched with oligomerized tau
The THY-Tau22 transgenic mouse model of AD-like tauo-
pathy (Tg) develops progressive tau hyperphosphorylation
and aggregation from 3months of age that reaches a max-
imum at 12months [70]. At 6months of age, Tg mice ac-
cumulate soluble prefibrillar tau oligomers in the cytoplasm
of CA1 neurons of the hippocampus (Fig. 1a) [6].
We monitored tau pathology by immunofluorescence
in CA1 neurons in sagittal sections from Tg and Wt
control mice using PT212 and TOC1 antibodies, which
recognize phosphorylated Thr212 and soluble oligomer-
ized tau, respectively [67, 86]. Hyperphosphorylated tau
was detected in both six-month-old (6-mo) and 12-
month-old (12-mo) Tg mouse CA1 neurons (Fig. 1b).
Complete co-localization of cytoplasmic signals from
PT212 and TOC1 antibodies was detected in CA1 neu-
rons from 6-mo Tg mice (Fig. 1b). Contrary to PT212,
TOC1 labeling was detected in almost all neurons in 6-
(See figure on previous page.)
Fig. 2 CA1 neurons in Tg mice show altered mitochondrial morphology. a Representative TEM images of CA1 sections from 6- and 12-mo Tg
and Wt mice hippocampus (n = 3 for each mouse category). Mitochondria are highlighted by transparent colored overlay. The scale bars
represent 5 μm or 1 μm. b Illustration of the quantification of mitochondrial area from TEM images. c Graph shows the mean of mitochondrial
area per mouse category (mitochondria: 6-mo-Wt n = 63; 6-mo-Tg n = 51; 12-mo-Wt n = 72; and 12-mo Tg n = 54). Data is presented as mean ±
SEM (*P = 0.039; **P = 0.0077). d WB analysis of extracts from 6-mo Wt and Tg mice CA1 (WT, n = 6; Tg, n = 7), using antibodies against
mitochondrial fission and fusion proteins: DRP1, pDRP1 (S616) and OPA1. Actin was used as loading control. e WB analysis of extracts from 12-mo
Wt and Tg mice hippocampi (Wt, n = 5; Tg, n = 5). Actin or Vinculin were used as loading control. Quantifications are shown in graphs. Data is
presented as mean ± SEM (*P < 0.05; **P < 0.01). f WB analysis of extracts from 6-mo Wt and Tg mice CA1 (Wt, n = 6; Tg, n = 6) using an antibody
cocktail against selected OXPHOS assembly subunits (CI: NDUFB8; CII: SDHB; CIII, MTCO1; CIV: UQCRC2; CV: ATP5A). g Graph showing the
quantification results normalized to GAPDH. Data are shown as mean ± SEM (*P < 0.05)
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mo Tg mice, but was no longer detectable in 12-mo Tg
mice (Fig. 1b). Thus, prefibrillar, oligomeric tau is preva-
lent in Tg mice CA1 neurons early in the course of tau
pathology but is not detectable at a later stage when tau
pathology has reached its maximum [70].
Altered mitochondrial morphology and the abundance of
OXPHOS subunits in Tg mouse hippocampal neurons
Mitochondrial morphology is a key indicator of the state
of cellular and tissue mitochondrial function and health
[1, 71, 92, 93]. Transmission electron microscopy (TEM)
analysis revealed an enrichment of elongated hippocam-
pal mitochondria in Tg mice compared with Wt mice,
which was more pronounced in 6-mo Tg mice than in
12-mo Tg mice (Fig. 2a, b and c).
Mitochondria undergo fusion and fission resulting in
elongated or smaller mitochondria, respectively. Key
proteins that regulate mitochondrial fission and fusion
include the cytosolic dynamin-related protein 1 (DRP1)
and the mitochondrial inner membrane protein optic at-
rophy 1 (OPA1), respectively [13]. The level of DRP1 in
CA1 from 6-mo Tg mice was significantly lower than in
the CA1 from 6-mo Wt mice (Fig. 2d). Phosphorylation
of DRP1 at S616 (pDRP1) promotes the recruitment of
DRP1 onto mitochondria and initiates the fission process
[79]. There was no difference in the ratio of pDRP1/
DRP1 suggesting that at 6 months of age, the reduced
fission in Tg mice CA1 is caused by downregulation of
DRP1 expression or increased protein turnover (Fig. 2d).
Neither the amount of total DRP1, nor the level of
pDRP1, were different between 12-mo Tg and Wt
mouse hippocampi (Fig. 2e), suggesting that the reduced
level of DRP1 in Tg mice was age dependent, occurs at
early stages of tau pathology, and may contribute to the
observed increased number of elongated mitochondria
in Tg mouse hippocampi (Fig. 2a and b). The level of
the mitochondrial inner membrane fusion protein
OPA1, however, was not significantly different between
Tg and Wt mice at any age, but a decrease was trending
lower (P = 0.06) in 12-mo Tg mice (Fig. 2d and e).
The structure of the mitochondrial inner membrane de-
termines the assembly and efficiency of the mitochondrial
oxidative phosphorylation (OXPHOS) complexes (CI-CV)
[17], linking mitochondrial morphology to mitochondrial
function [93]. WB analysis showed reduced levels of CIII,
CIV, and CV in 6-mo Tg hippocampus compared with
the Wt mice (Fig. 2f). In 12-mo Tg mice, however, the
level of CIV was higher compared with Wt mice while the
levels of CIII and CV were not (Fig. 2g).
Thus, at 6months of age, hippocampal neurons in Tg
mice are accumulating tau oligomers, and displaying alter-
ations in the structure and morphology of mitochondria.
These observations, link tau oligomerization to altered mito-
chondrial fission and to OXPHOS structure and function.
Elevated mitochondrial stress response in Tg mice
hippocampus
Mitochondrial dysfunction is frequently associated with
mitochondrial stress phenotypes such as increased non-
enzymatic acetylation of mitochondrial proteins typically
resulting in altered function of the modified proteins
[27, 87, 92]. Sirtuin 3 (SIRT3) is a mitochondrial NAD+-
dependent deacetylase that maintains mitochondrial
homeostasis under stress conditions by removing acetyl-
ation lesions from mitochondrial proteins [15, 55, 87].
WB analysis showed that the amount of SIRT3 in CA1
from 6-mo Tg mice was markedly higher than in CA1
from Wt mice (Fig. 3a), probably in response to perpet-
ual mitochondrial stress.
Superoxide dismutase 2 (SOD2) is an important mito-
chondrial antioxidant enzyme. SIRT3 deacetylates and
activates SOD2 [14, 80]. The level of acetylated SOD2,
but not total SOD2, was significantly lower in 6-mo Tg
mice CA1 compared with CA1 from Wt mice (Fig. 3a),
consistent with higher levels of SIRT3. There were, how-
ever, no differences in the level of SIRT3, total SOD2 or
acetylated SOD2 in 12-mo mice (Fig. 3b).
Mitophagy is the process of selective autophagic elimin-
ation of mitochondria. PTEN-induced putative kinase 1
(PINK1) accumulates on the outer mitochondrial mem-
brane of damaged mitochondria with impaired membrane
potential, thereby targeting the damaged mitochondria for
mitophagy and lysosomal engulfment and degradation [36].
CA1 extracts from 6-mo but not from 12-mo Tg mice,
contained higher amounts of PINK1 than Wt mice (Fig. 3c,
d). This suggests the presence of more depolarized dysfunc-
tional mitochondria in 6-mo Tg CA1 neurons.
Lipidated LC3 (LC3-II) facilitates substrate uptake by
autophagosomes through binding to autophagy recep-
tors. WB analysis of the ratio between nonlipidated
(See figure on previous page.)
Fig. 3 CA1 Tg mice undergo mitochondrial stress. a WB analysis of extracts from 6-mo Wt and Tg mice CA1 (Wt, n = 6; Tg, n = 7), using
antibodies against SIRT3, SOD2 and acetylated SOD2. b WB analysis of extracts from 12-mo Wt and Tg mice hippocampi (Wt, n = 5; Tg, n = 5).
Data are presented as mean ± SEM (**P < 0.01; ***P < 0.001). WB analysis of extracts from 6-mo Wt and Tg mice CA1 (Wt, n = 6; Tg, n = 5) (c), and
from 12-mo Wt and Tg mice hippocampi (Wt, n = 5; Tg, n = 5) (d) for PINK1 and LC-3. Data are presented as mean ± SEM, *P < 0.05. WB analysis of
extracts from 6-mo WT and Tg mice CA1 (WT, n = 5; Tg, n = 6) (e), and from 12-mo WT and Tg mice hippocampi (WT, n = 5; Tg, n = 5) (f) for
TFAM. Data are presented as mean ± SEM (*P < 0.05), **P < 0.01). Actin was used as loading control
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LC3I/ to lapidated LC3-II has been used as a marker to
monitor autophagic flux and response [31, 40]. There
were no detectable differences in LC3-I/LC3-II ratio be-
tween Tg and Wt mice CA1 extracts, suggesting a simi-
lar basal autophagic flux (Fig. 3c, d).
The mitochondrial transcription factor A (TFAM) is an
abundant protein with a central role in the initiation of
mtDNA transcription and regulation of mtDNA replica-
tion [28]. Recently, cells from the long-lived Snell dwarf
mice were shown to increase the expression of TFAM
which improved mitochondrial stress response probably
contributing to their increased lifespan [63]. The level of
TFAM was higher in CA1 from Tg mice at both six and
12months of age compared with Wt mice (Fig. 3e and f).
WB analysis of whole CA1 extracts for VDAC1 showed
no significant differences in mitochondrial mass in CA1
from 6-mo Tg and Wt mice (Suppl. Figure 1), indicating
that TFAM was specifically increased in Tg mice CA1.
The transcriptional co-activator PGC-1α is an import-
ant regulator of mitochondrial biogenesis [69]. There
were no detectable differences in the expression of PGC-
1α between Tg and Wt mice (Suppl. Figure 2). Notably,
the activity of PGC-1α is controlled by phosphorylation
and acetylation [35, 61], detection of which often re-
quires an immunoprecipitation step [26], which was not
attempted here because of material limitation.
Thus, 6-mo Tg mice display altered expression and ac-
tivity of SIRT3 with decreased ac-SOD2 and increased
expression of PINK1, while TFAM expression was
higher in Tg mice than the control mice at both ages.
These results are all consistent with response to mito-
chondria experiencing elevated stress.
The levels of the mitochondrial protein ANT1 and VDAC1
are markedly changed in Tg mouse CA1 neurons with tau
lesion
Adenine nucleotide translocator 1 (ANT1) is a highly
abundant mitochondrial protein with important roles in
the regulation of ADP/ATP exchange and mitochondrial
membrane potential [8]. WB analysis did not show any
differences in the ANT1 levels in lysates from 6- and 12-
mo Tg and age-matched WT mice (data not shown).
Immunofluorescence analysis, however, showed that the
level of ANT1 was significantly reduced in 6-mo Tg
mice CA1 neurons displaying high levels of tau oligo-
mers compared with the Wt mice CA1 neurons (Fig. 4a).
No differences were detected in 12-mo animals (Fig. 4b).
Voltage-dependent anion channel 1 (VDAC1), is an
abundant mitochondrial outer membrane protein that
plays central roles in various mitochondrial function
[11]. The overall level of VDAC1 in 6-mo Tg mice CA1
was comparable to that in Wt mice (Fig. 4c, and Suppl.
Figure 1). In 12-mo Tg mice CA1, however, the level of
VDAC1 was significantly higher in neurons that also dis-
played high levels of cytoplasmic hyperphosphorylated
tau compared with the rest of CA1 cells (Fig. 4d). Thus,
the expression of mitochondrial proteins ANT1 and
VDAC1 in Tg mice CA1 neurons are differently affected
by age and the status of tauopathy.
CA1 from 6-mo Tg mice contain increased copies of
mtDNA molecules
The number of mtDNA molecules in a mitochondrion
correlates with the cellular energy demand of the cell
and ATP production and has been used to assess the
state of mitochondrial function [16, 30]. CA1 from 6-mo
(Suppl. Figure 3A) but not from 12-mo Tg mice (Suppl.
Figure 3B) contained higher mtDNA copy numbers
compared with CA1 from the Wt mice.
There were no significant differences in ATP levels in
CA1 from 6-mo Tg mice compared to CA1 from Wt
mice (Suppl. Figure 4), suggesting comparable levels of
ATP production and perhaps consumption despite the
morphological and mtDNA copy number differences.
CA1 extracts from 6-mo Tg mice display elevated BER
activity
BER is the prominent pathway for repair of oxidative
DNA damage and is active in both the nucleus and
mitochondria [2, 78]. To test the biochemical effects of
the observed mitochondrial stress in Tg mice, we carried
out BER analyses in CA1 extracts. 8-oxo-G removal and
(See figure on previous page.)
Fig. 4 Altered levels of the mitochondrial proteins ANT1 and VDAC1 in Tg mice. Representative images of sagittal CA1 sections from 6- (a), and
12-mo (b), Tg and Wt mice hippocampi. The sections were labeled using TOC1 (against soluble tau oligomers) (a), pathological phosphorylated
tau AT8 (against the phosphorylated tau at Ser202/Thr205) (b), and anti-ANT1 antibodies (n = 3 for each mouse category). Immunofluorescence
signals were analyzed using laser scanning confocal microscopy (z projection). Nuclei were visualized with DAPI staining. The scale bars represent
20 μm. The cellular ANT1 fluorescence intensity was quantified within CA1 cells from 6- and 12-mo Wt and Tg hippocampi (cells: 6-mo Wt, n =
106; 6-mo Tg, n = 52; 12-mo Wt, n = 63; 12-mo Tg, n = 55). Graph shows the mean of cellular fluorescence per mouse category. Data are
presented as mean ± SEM (*P < 0.05). Representative images of sagittal CA1 sections from 6- (c) and 12-mo (d) Wt and Tg mice hippocampi. The
sections were labeled with antibodies against phosphorylated tau (pThr212), and VDAC1 (n = 3 for each mouse strain). Immunofluorescence
signals were analyzed using laser scanning confocal microscopy (z projection). Nuclei were detected with DAPI staining. The scale bars represent
20 μm. The cellular VDAC1 fluorescence intensity was quantified within CA1 cells (6-mo Wt, n = 50; 6-mo Tg, n = 41; 12-mo Wt, n = 90; 12-mo Tg,
n = 118). Graph shows the mean of cellular fluorescence per mouse category. Data are presented as mean ± SEM (**P < 0.01)
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DNA polymerase β (Polβ) repair DNA synthesis activ-
ities were markedly higher in CA1 extracts from 6-mo
Tg mice compared with the Wt mice (Fig. 5c, d), but
not in hippocampal extracts from 12-mo Tg mice
(Suppl. Figure 5). These results suggest a tau-dependent
and age-specific increase in BER activity in CA1, perhaps
as a part of the cellular response to oxidative stress.
Increased levels of nuclear OGG1 and 8-oxo-G in 6-mo Tg
mice hippocampal neurons
8-oxo-guanine DNA glycosylase (OGG1) is the major en-
zyme for removal of 8-oxoG lesions from DNA. WB ana-
lysis showed a significantly higher amounts of OGG1 in
hippocampal extracts from 6-mo but not from 12-mo Tg
mice compared with Wt mice (Fig. 5f and g), corroborat-
ing the biochemical results (Fig. 5c, and Suppl. Figure 5).
Immunofluorescence analysis of CA1 sections showed
significantly increased levels of OGG1 mainly in the nu-
cleus of CA1 neurons in 6-mo Tg mice (Fig. 5h). Co-
staining of OGG1 and VDAC1 did not show discernable
co-localization signals, suggesting the absence or very
low levels of OGG1 in mitochondria in CA1 neurons in
6-mo Tg mice (Fig. 5i and j).
CA1 hippocampal neurons from 6-mo Tg mice
showed a higher level of 8-oxo-G base lesion signal com-
pared with Wt control mice illustrating increased oxida-
tive DNA damage (Fig. 5k). 8-oxo-G signal was
restricted to nuclei suggesting that mtDNA did not con-
tain discernible amounts of oxidative base lesions.
Thus, 6-mo Tg mice CA1 hippocampal neurons
undergo elevated oxidative stress. The increased 8-oxo-
G removal activity (Fig. 5c) and the levels of OGG1
protein (Fig. 5f) are likely part of the cellular response to
increased oxidative stress.
Altered level and intracellular distribution of Polβ in 6-mo
Tg mouse hippocampal neurons and human AD brain
Polβ is a key BER protein, and likely the rate limiting
one. It is predominantly a nuclear protein, but was re-
cently detected in the mitochondria where it is likely in-
volved in mtDNA repair [65, 76].
Because Polβ activity was increased in CA1 hippocam-
pus from 6-mo Tg mice (Fig. 5d), we examined the effect
of early tau pathology on the expression and cellular
localization of Polβ within CA1 neurons. WB analysis and
immunofluorescence analysis of CA1 sections showed no
significant differences in Polβ levels in, respectively, CA1
extracts and CA1 cells from Tg and WT mice (Suppl. Fig-
ure 6, Fig. 6a). However, the level of nuclear Polβ was sig-
nificantly reduced in 6-mo Tg mice (Fig. 6a). This was not
observed in 12-mo Tg mice (Suppl. Figure 7).
Moreover, an increased overall cellular Polβ fluores-
cence signal was observed in CA1 cells from 6-mo Tg
mice with tau hyperphosphorylation (High Ptau) (Fig. 6a).
Because the level of nuclear fluorescence of Polβ did not
significantly change in these cells, this shows that the in-
creased tau phosphorylation correlates with an increased
level of cytoplasmic Polβ (Fig. 6a). While the overall level
of Polβ is unchanged in Tg compared to Wt mice (Suppl.
Figure 6, Fig. 6a), interestingly, Polβ translocates from the
nucleus to the cytoplasm in CA1 cells with tau hyperpho-
sphorylation in 6-mo Tg mice.
Immunofluorescence co-labeling of Polβ and VDAC1
revealed co-localization of cytosolic Polβ with VDAC1, sug-
gesting that Polβ is located within or onto mitochondria in
(See figure on previous page.)
Fig. 5 Increased levels of BER activity, 8-oxo-G base lesion, and OGG1 DNA glycosylase in CA1 neurons in 6-mo Tg mice. Biochemical analysis of
BER activity in CA1 extracts from 6-mo Tg and Wt mice. a AP-site incision activity. Recombinant APE1 protein was used as a positive control. b
Uracil removal activity. Purified recombinant UNG was used as a positive control. c 8-oxo-dG removal activity. Formamidopyrimidine DNA
glycosylase (FPG) was used as a positive control. d Polβ nucleotide incorporation activity. e Quantifications of A-D, data are presented as mean ±
SEM (*P < 0.05). WB analysis of CA1 extracts from 6-mo Wt (n = 5) and Tg (n = 6) mice (f), and hippocampus extracts from 12-mo Wt (n = 5) and
Tg (n = 5) mice (g) for OGG1. Actin was used as a loading control. Quantification results are shown in the graph below. Data are presented as
mean ± SEM (***P < 0.001). h Representative images of sagittal CA1 sections from 6-mo Wt and Tg mice. The sections were co-labeled with AT8
and anti-OGG1 antibodies (n = 3 for each mouse strain). The immunofluorescence signals were analyzed by laser scanning confocal microscopy (z
projection). DAPI staining was used to visualize nuclei. Representative nuclei are delimitated by white dashed lines. The scale bars represent
20 μm. The cellular and nuclear OGG1 fluorescence intensity was quantified within CA1 cells (cells: Wt, n = 18; Tg, n = 18)(nuclei: Wt, n = 68; Tg,
n = 116). Graph shows the mean of cellular or nuclear fluorescence per mouse category. Data are presented as mean ± SEM (**P < 0.01). i Possible
mitochondrial localization of OGG1 was determined by labeling sagittal CA1 sections from 6-mo Wt and Tg mice with anti-VDAC1 and anti-OGG1
antibodies (n = 3 for each mouse strain). Immunofluorescence labeling was analyzed using laser scanning confocal microscopy (single confocal
section). DAPI staining was used to visualize nuclei. The scale bars represent 20 μm. Representative nuclei are delimitated by white dashed lines.
The scale bars represent 10 μm. j Overlay of VDAC1 and OGG1 Immunofluorescence signals. The scale bars represent 20 μm. k Representative
images of sagittal CA1 sections from 6-mo Wt and Tg mice hippocampi (n = 3 for each mouse strain). The sections were labeled with the 8-oxo-G
antibody after RNAse pretreatment as described before [84] to selectively target oxidative DNA lesions (8-oxo-G). Immunofluorescence signals
were analyzed using laser scanning confocal microscopy (z projection). Nuclei were detected with DAPI staining. Representative nuclei are
delimitated by white dashed lines. The scale bars represent 20 μm. The intensity of the nuclear 8-oxo-G fluorescence signals was quantified within
CA1 cells from 6-mo Wt and Tg hippocampi (nuclei: 6-mo Wt, n = 98; 6-mo Tg, n = 343). Graph shows the mean of cellular or nuclear
fluorescence per mouse category. Data are presented as mean ± SEM (***P < 0.001). S, substrate; P, repair product
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CA1 neurons in 6-mo Tg mice (Fig. 6b and c). Immunoe-
lectron microscopy using anti-Polβ antibody showed in-
creased Polβ signals within mitochondria in 6-mo Tg mice
compared to Wt (Fig. 6d, and Suppl. Fig. 8), further demon-
strating the accumulation of Polβ within mitochondria in
CA1 cells with hyperphosphorylated/oligomerized tau in 6-
mo Tg mice.
These results suggest a potential role of Polβ in
mtDNA repair in CA1 cell. We tested this using a PCR-
based method [68, 92]. This method, as used here,
mostly detects AP-sites in DNA. There were no detect-
able differences in the level of mtDNA integrity in CA1
from 6-mo and 12-mo Tg and Wt mice (Suppl. Figure 9).
This suggests that the enrichment of Polβ in mitochon-
dria in the neurons with hyperphosphorylated/oligomer-
ized tau may contribute to the preservation of the
mtDNA integrity in those cells that is comparable to Wt
mice CA1; however, this needs further investigation.
We next investigated the relevance of these findings
to human tau pathology. We found specific cytoplasmic
accumulation of Polβ in neurons positive for soluble tau
oligomers in frontal cortex from human AD brains
(Fig. 6e and Suppl. Fig. S11). Cytoplasmic Polβ labeling
was detected in all the cells that also showed the accu-
mulation of tau oligomers. Co-labeling of Polβ and
VDAC1 in the same brain samples highlighted strong
co-localization signal (Fig. 6f and Suppl. Fig. S11). Thus,
our results demonstrate a correlation between extra nu-
clear and mitochondrial localization of Polβ and the
presence of soluble oligomerized tau protein in Tg
mouse CA1 (Fig. 6a, b, c and d) and in frontal cortex
from human AD brains (Fig. 6e, f and Suppl. Fig. 11).
Tau oligomerization and mitochondrial stress do not lead
to significant CA1 neuronal loss
Mitochondrial dysfunction may trigger cell death by
apoptosis [83]. Caspases are central mediators of neur-
onal apoptosis. Activated caspase-3 has been detected in
hippocampus in AD mouse models, and was related to
increased DNA damage and neuronal death [77], but
also to early synaptic dysfunction without cell death
[20]. Immunofluorescence analysis of CA1 sections did
not show detectable levels of activated caspase-3 in Tg
or in Wt mice (Fig. 7a). Rare caspase-3 activated apop-
totic events may be difficult to detect. Thus, we quanti-
fied the DAPI-stained nuclei to determine the cell
density in the CA1 section as a measure of cell loss. A
slight but statistically significant decrease in cell density
was detected in 12-mo Tg mouse CA1 compared with
CA1 from 12-mo Wt mice (Fig. 7b). WB analysis
showed very faint bands corresponding to the expected
size of cleaved caspase-3 in CA1 extracts from 12-mo
Wt and Tg mice (Fig. 7c). Together, these results sug-
gest that tau oligomerization and the mitochondrial al-
terations observed in 6-mo Tg CA1 cells do not lead to
a detectable level of CA1 neuronal loss; however, at later
stages of tau pathology, some neuronal loss in CA1 may
take place as previously described [70]. It is noteworthy,
however, that the use of a stereological tool like opti-
mized optical fractionator would be necessary for un-
biased estimation of neuronal number [33].
Discussion
In this study, we show that at early stages of tau path-
ology when soluble tau oligomers are prominent,
(See figure on previous page.)
Fig. 6 Cytoplasmic and mitochondrial accumulation of Polβ in 6-mo Tg mice hippocampal neurons. a Representative images of sagittal CA1
sections from 6-mo Wt and Tg mice hippocampi (n = 3 for each phenotype). The sections were co-labeled with anti-phospho-tau (AT8), and Polβ
antibodies (n = 3 for each mouse category). Immunofluorescence signals were analyzed using laser scanning confocal microscopy (z projection).
Nuclei were detected with DAPI staining. Representative nuclei are delimitated by white dashed lines. The scale bars represent 20 μm.. The
intensity of the cellular and nuclear Polβ fluorescence signals was quantified within CA1 cells from 6-mo Wt and Tg hippocampi (cells: Wt, n = 64;
Tg, n = 47; nuclei: Wt, n = 142; Tg, n = 88). Graph shows the mean of cellular or nuclear fluorescence per mouse category. Data are presented as
mean ± SEM (*P < 0.05; **P < 0.01). The intensity of the cellular and nuclear Polβ fluorescence signals was separately quantified within CA1 cells
from 6-mo Tg hippocampi with either high (High Ptau) or low phospho-tau (Low Ptau) levels (cells: Low Ptau n = 53, High PTau n = 27; nuclei Tg:
Low Ptau n = 37, High PTau n = 47). Data are presented as mean ± SEM (*P < 0.05; **P < 0.01). The cut off value of fluorescence between high
and low phospho-tau levels has been arbitrary chosen based on visual evaluation of the cytoplasmic phospho-tau labeling. b Mitochondrial
localization of Polβ was assessed by labeling sagittal CA1 sections from 6-mo Wt and Tg mice with VDAC1 and Polβ antibodies (n = 3 for each
mouse strain). Immunofluorescence signals were analyzed by laser scanning confocal microscopy (single confocal section). The scale bars
represent 10 μm. Representative nuclei are delimitated by white dashed lines. White arrows point VDAC1 and Polβ co-localization. c Overlays of
immunofluorescence labeling of VDAC1 and Polβ. d Representative immunoelectron microscopy images of CA1 sections from 6-mo Tg and Wt
mice hippocampus. The sections were labeled with Polβ antibodies (n = 3 for each mouse strain). The scale bars represent 100 nm. Red arrows
point Polβ localization. e Representative images of frontal cortex sections from human control (Ctr) and Braak VI Alzheimer frontal cortex (AD).
The sections were labeled with the tau oligomer antibody, TOC1, and anti-Polβ antibody (n = 3 for each category). Immunofluorescence signals
were analyzed by laser scanning confocal microscopy (z projection). Nuclei were detected with DAPI staining. Representative nuclei are
delimitated by white dashed lines. The scale bars represent 20 μm. f Immunofluorescence labeling of the same sections with antibodies against
Polβ and VDAC1 demonstrates mitochondrial localization of Polβ. Immunofluorescence signals were analyzed by laser scanning confocal
microscopy (single confocal section). Nuclei were detected with DAPI staining. Representative nuclei are delimitated by white dashed lines. The
scale bars represent 20 μm. White arrows point VDAC1 and Polβ localization
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hippocampal neurons undergo significant changes in
mitochondrial homeostasis, DNA repair activity, and
cytosolic and mitochondrial translocation of Polβ
(Fig. 8a). These events likely promote cell survival and
counter cellular stress caused by tau oligomers.
Prefibrillar oligomers have emerged as the more dele-
terious forms of tau rather than the previously thought
larger tau aggregates [29, 32, 46, 60, 64, 84] and other
pathogenic tau species in AD [46]. In cell models, oligo-
meric tau intermediates have been described as neuronal
Fig. 7 Accumulation of oligomeric tau in 6-mo Tg mice does not lead to detectable level of apoptotic cell death. Representative images of
sagittal CA1 sections from 6- and 12-mo Wt and Tg mice hippocampi (n = 3 for each category), labeled with antibodies against the phospho-tau
(AT8), and activated (cleaved) caspase-3 antibodies. Immunofluorescent signals were analyzed by LSC laser scanning confocal microscopy (z
projection). Nuclei were visualized with DAPI staining. The scale bars represent 20 μm. b Quantification of nuclei (DAPI staining) per surface unit
within CA1 sections from 6- and 12-mo Wt and Tg mice hippocampi (n = 10 for each mouse category). DAPI signals were analyzed by LSC laser
scanning confocal microscopy (z projection). Graph shows the mean of nuclear fluorescence per mouse. Data are presented as mean ± SEM
(***P < 0.001). c WB analysis of CA1 lysates from 6- and 12-mo mice and hippocampi for pro-caspase-3 and activate cleaved caspase-3. Actin was
used as loading control
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death inducers [29, 44]. Injection of recombinant hu-
man tau oligomers into mouse hippocampus pro-
duced mitochondrial respiratory chain dysfunction,
activated the pro-apoptotic protein caspase-9 and in-
duced neurodegeneration in the CA1 region [45].
However, if endogenous soluble tau oligomers in-
duced cell death in AD brains, neurons with insoluble
aggregates and NFT should not be observed. This
suggests that in human brains, neurons with tau path-
ology develop efficient mechanisms to counter the
cell toxicity caused by soluble tau oligomers and pro-
mote neuronal survival.
Consistent with this hypothesis, our results show that
CA1 neurons in 6-mo Tg mice with prominent
Fig. 8 a Schematic summary of mitochondrial and BER alterations in hippocampus neurons from 6- and 12-mo Tg mice detected in this study.
b Schematic roles of soluble tau oligomers in disease progression
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endogenous prefibrillar tau oligomers in the cytoplasm,
activate a cellular stress response and show no evidence
for increased cell death.
A recent study showed that the method of tau oligo-
mers preparation and other experimental conditions
might account for the observed cytotoxicity of tau oligo-
mers [38]. Under improved experimental conditions, tau
oligomers caused synaptotoxicity, increased ROS pro-
duction, and impaired calcium homeostasis, but had no
overt effects on cell viability [38]. These findings are
largely in line with our conclusions. We cannot, how-
ever, rule out that some populations of neurons may fail
to develop effective pro-survival mechanisms against tau
oligomers-induced toxicity and die, thus, contributing to
early neuronal loss observed in AD.
SIRT3 is the primary mitochondrial NAD+-dependent
deacetylase [52]. In stressful conditions such as excito-
toxicity and high ROS production, SIRT3 maintains
mitochondrial homeostasis and promotes neuronal
stress resistance and survival [21, 39, 66]. Oxidative and
metabolic stress modulate the expression of SIRT3 [55].
A decrease in SIRT3 protein level was linked to mito-
chondrial dysfunction in AD brain [48]. Increased level
and activity of SIRT3 (Fig. 3a) concomitant with the en-
richment of prefibrillar tau oligomers in 6-mo Tg mouse
CA1 region, suggests that CA1 neurons are undergoing
stress and activate SIRT3 as part of a stress response to
sustain mitochondrial function and to promote the sur-
vival of neurons developing tau pathology.
Mitochondria are structurally dynamic organelles and
undergo fusion and fission resulting in elongated and
smaller mitochondria, respectively. Fusion and fission
are implicated in the elimination of abnormal mitochon-
dria by mitophagy [81], maintaining mtDNA integrity
[24], regulating mitochondrial morphology [51], and
mitochondria distribution within the cell [50]. The cen-
tral fission protein is the cytosolic DRP1. In 6-mo Tg
mice hippocampal cells enriched with tau oligomers, the
level of DRP1 was significantly reduced together with
mitochondrial elongation linking altered expression of
DRP1 to mitochondrial morphology changes early dur-
ing tau pathology.
DRP1 interacts with hyperphosphorylated tau in AD
brain [53]. Interestingly, reduced DRP1 and increased
mitochondrial fusion protected against various tau-
induced mitochondrial dysfunction in the cortex and
hippocampus of a double mutant P301L tau and DRP1
heterozygous knockout mice [37]. Thus, the reduced
DRP1 level and mitochondrial elongation may constitute
a key mechanism to maintain mitochondrial homeostasis
and to promote cell survival in 6-mo Tg mice CA1 hip-
pocampal neurons. In 12-mo Tg mice, mitochondrial
elongation decreased but persists despite DRP1 return-
ing to Wt levels.
ANT1 transports ADP and ATP across the mitochon-
drial inner membrane. ANT1-deficient mice do not
show overt brain pathology, and ANT1-deficient neu-
rons are resistant to excitotoxicity induced death [49].
Thus, it is possible that the significant reduction in the
expression of ANT1 in 6-mo Tg mice CA1 neurons
(Fig. 4a) provides a neuroprotective function, maybe as
part of a mitochondrial and neuronal stress response to
tau oligomers.
The mitochondrial outer membrane protein VDAC1
plays central roles in regulating mitochondrial function
and mitochondrial-related apoptosis [11]. VDAC1 has
been linked to AD pathogenesis [73] and VDAC1 inter-
action with hyperphosphorylated tau negatively affected
mitochondrial function [54]. The increased concentra-
tion of VDAC1 in hyperphoshorylated tau-expressing
CA1 neurons in 12-mo Tg mice, but not in 6-mo Tg
mice, is in line with a previous report showing high ex-
pression of VDAC1 in AD brains at advanced stages of
the disease and in AD transgenic mouse brain [18].
Overexpression of VDAC1 induces apoptotic cell death
in various cell types [90], consistent with the reduced
cell density seen in 12-mo Tg CA1 neurons (Fig. 7b).
Thus, our results suggest that most of the neuro-
protective stress responses in 6-mo Tg mice CA1 neurons
are transient and effective in the early stages of tau pathology
when tau oligomers are abundant. Notably, an adaptive pro-
survival response triggered by mitochondrial stress has been
recently described in human skeletal muscle cells [56].
8-oxo-G is the major oxidative DNA base lesion and is
frequently used as a biomarker of the state of cellular
stress and ROS generated DNA damage [22]. OGG1 is
the major DNA glycosylase for the removal of 8-oxo-G
from DNA [43]. Our results showed increased 8-oxo-G
levels together with enhanced OGG1 protein level and
8-oxo-G repair activity in the 6-mo Tg mice CA1 neu-
rons. Thus, we have identified a combination of in-
creased DNA lesions and the activity that repairs those
lesions as a novel consequence of tau oligomerization.
Polβ deficiency exacerbates AD phenotypes and mito-
chondrial dysfunction [34, 58, 77], and post- mortem brain
extracts from AD patients showed impaired Polβ activity
[88]. Polβ is the central nuclear BER DNA polymerase in
mammalian cells. Mice with targeted disruption of Polβ die
shortly after birth [74]. Histological examination of the em-
bryos revealed a key role for Polβ in neurogenesis and neur-
onal development [74]. Polβ is predominantly present in
the nucleus; however, recently, Polβ has also been detected
in mitochondria where it contributes to mtDNA integrity
[65, 76]. The localization of Polβ in mitochondria appears
to be tissue dependent and controlled by an unknown
mechanism, because it was found in mouse brain mito-
chondria but not in the liver mitochondria [76]. Thus,
under normal physiological conditions, Polβ is present in
Zheng et al. Acta Neuropathologica Communications            (2020) 8:25 Page 18 of 23
the brain nuclei and mitochondria. However, the transloca-
tion of Polβ from the nucleus to mitochondria appears
more prominent under cellular stress conditions generated
by tau oligomerization (Fig. 6). These results suggest a pro-
tective function of mitochondrial localization of Polβ in the
brain that may involve mtDNA repair [76]. However, other
hitherto unknown functions cannot be ruled out and this is
an interesting and important subject for investigation. Im-
portantly, this is the first demonstration of mitochondrial
localization of Polβ in the etiology of tauopathy and AD.
Tau oligomers are thought to be neurotoxic and cause
mitochondrial dysfunction [44, 45]. Our results, how-
ever, reveal several protective mechanisms, e.g. increased
SIRT3 (Fig. 3a), mtDNA copy number (Suppl. Figure 3),
BER activity (Fig. 5c and d), and reduced DRP1 and
ANT1 levels (Fig. 2d and 4a), in response to tau lesion,
probably allowing neurons to prevent irreversible mito-
chondrial dysfunction and cell death (Fig. 8b). The bene-
fit of these protective mechanisms early in tau pathology
might, however, contribute to the long-term survival of
neurons expressing tau pathology [59], and in that way
contribute to the progression of AD and related
tauopathies.
An important finding in our work is that almost all
mitochondrial, as well as DNA damage and repair, phe-
notypes observed in 6-mo Tg mice hippocampus were
reversed or corrected to the level of Wt mice when the
mice were 12 months old. The protective response cor-
related to the presence of tau oligomers was not a sec-
ondary effect of tau overexpression, because the level of
tau actually substantially increased over time (Fig. 2d, e).
In human AD brains, intraneuronal accumulation of
soluble tau oligomers correlates with synaptic alter-
ations, neuroinflammation and memory deficits [32, 42,
62]. Notably, synaptic loss, neuroinflammation, and
memory deficit, but no cell loss, have been reported in 6
months old THY-Tau22 mice bred in the same lab (66,
44). This suggests that the endogenous soluble tau oligo-
mers have a deleterious effect on neuronal function, un-
related to cell death. Altogether, our results suggest that
in 6-mo THY-Tau22 mice, CA1 neurons develop mech-
anisms to protect against cell toxicity and cell death
caused by soluble tau oligomers, but fail to prevent fully
soluble tau oligomers from triggering cellular dysfunc-
tions. Cellular alterations elicited by soluble tau oligo-
mers will persist and participate in progressive neuronal
dysfunction and behavioral deficits despite the decrease
or loss of toxic oligomeric tau at later stages of the path-
ology (Fig. 8b).
A number of recent studies have investigated various
intervention strategies to improve or correct key disease
phenotypes in animal models of human neurodegenerative
diseases including AD [25, 26, 34]. These studies have dem-
onstrated mitochondria and DNA damage responses as
potentially safe therapeutic targets. It will be interesting to
investigate the effect of these drugs on the progression of
tau pathology and neuronal stress response in THY-tau22
mouse.
In summary, our data suggests that early during the
development of tau pathology, when soluble prefibrillar
tau oligomers are prominent and cells undergo stress,
CA1 hippocampal neurons activate pro-survival mito-
chondrial and DNA repair stress responses. However,
these protective mechanisms may also allow the progres-
sive accumulation of tau aggregates in affected neurons,
and increasing risk of propagation of pathological forms
of tau to neighboring neurons over time, as observed in
AD. Notably, while extranuclear Polβ in hyperpho-
sphorylated and oligomerized tau overexpressing cells
may have a positive effect on mtDNA integrity, it may
have a deleterious effect on nuclear BER whereby pro-
moting genomic instability observed in early AD [7, 72,
84]. Thus, although soluble tau oligomers represent
plausible targets for treatment [12], controlling pro-
survival mechanisms as a therapeutic strategy needs
careful investigation.
To our knowledge, this work provides the first descrip-
tion of multiple stress responses implicating mitochon-
drial homeostasis and BER early during the progression
of tau pathology and tau oligomerization (Fig. 8). In our
view, these results represent an important advance in
the etiopathogenesis of tauopathies. We speculate that
the activation of pro-survival stress response trigged by
tau oligomers contributes to the progressive neuronal
dysfunction and the strong age-associated clinical mani-
festations of tauopathies (Fig. 8a, b). Elucidating the
underlying molecular mechanisms that control these
events and the consequences of their failure to the pro-
gression of tau pathology and neuronal dysfunction war-
rants investigation.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s40478-020-00896-8.
Additional file 1 : Figure S1. Tau pathology does not affect
mitochondrial mass in CA1 neurons. WB analysis of extracts from 6-mo
Wt and Tg mice CA1 (Wt, n = 6; Tg, n = 5) (A), and from 12-mo Wt and
Tg mice hippocampi (Wt, n = 5; Tg, n = 6) (B) for VDAC1. Actin was used
as loading control. Data are presented as mean ± SEM.
Additional file 2 : Figure S2. Tau pathology does not affect the
expression of the key regulator of mitochondrial biogenesis Pgc1α. WB
analysis of extracts from 6-mo Wt and Tg mice CA1 (Wt, n = 6; Tg, n = 5)
(A), and from 12-mo Wt and Tg mice hippocampi (Wt, n = 5; Tg, n = 6)
(B) for PGC-1α. Actin was used as loading control. Data are presented as
mean ± SEM.
Additional file 3 : Figure S3. Early tau pathology correlates with
increased number of mtDNA molecules. (A) Quantitative-PCR analysis of
mtDNA copy number was carried out in total DNA isolated from CA1 re-
gion from 6-mo Wt (n = 5) and Tg (n = 6) mice. Nd1 and 16 s rRNA are
mitochondrial genes and Hk2 is a nuclear gene. (B) Analysis of mtDNA
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copy number in total DNA from 12-mo Wt (n = 5) and Tg (n = 5) mice
hippocampi. Data are presented as mean ± SEM (*P < 0.05).
Additional file 4 : Figure S4. ATP measurements in 6-mo Tg and Wt
CA1. ATP was measured using a luciferase-based assay (ATPlite Lumines-
cence Assay Kit, PerkinElmer), following the Manufacturer’s protocol. The
content of ATP was normalized to protein content and presented as per-
centage of control.
Additional file 5 : Figure S5. BER activity is not changed in 12-mo Tg
mice. Biochemical analysis of BER activity in hippocampal extracts from
12-mo Tg and Wt mice. (A) AP-site incision activity. Recombinant APE1
protein was used as a positive control. (B) Uracil removal activity. Purified
recombinant UNG was used as a positive control. (C) 8-oxo-G removal ac-
tivity Formamidopyrimidine DNA glycosylase (FPG) was used as a positive
control. (D) Polβ nucleotide incorporation activity. (E) Quantifications of
A-D, data are presented as mean ± SEM.
Additional file 6 : Figure S6. Polβ protein level is not changed in Tg
mice. WB analysis of extracts from 6-mo Wt and Tg mice CA1 (Wt, n = 7;
Tg, n = 6) (A), and from 12-mo Wt and Tg mice hippocampi (Wt, n = 5;
Tg, n = 5) (B) for Polβ. Actin was used as loading control. Data are pre-
sented as mean ± SEM.
Additional file 7 : Figure S7. Absence of cytoplasmic accumulation of
Polβ in 12-mo Tg mice hippocampal neurons. Representative images of
sagittal CA1 sections from 12-mo Wt and Tg mice hippocampi. The sec-
tions were co-labeled with anti-phospho-tau (AT8), and Polβ antibodies
(n = 3 for each mouse category). Immunofluorescence signals were ana-
lyzed using laser scanning confocal microscopy (z projection). Nuclei
were detected with DAPI staining. Representative nuclei are delimitated
by white dashed lines. The scale bars represent 20 μm. The intensity of
the cellular and nuclear Polβ fluorescence signals was quantified within
CA1 cells from 12-mo Wt and Tg hippocampi (nuclei: Wt, n = 84; Tg, n =
66; cellular: Wt, n = 97; Tg, n = 98). Graph shows the mean of nuclear
fluorescence per mouse category. Data are presented as mean ± SEM.
Additional file 8 : Figure S8. Increased mitochondrial Polβ in Tg mice
hippocampal neurons. Representative immunoelectron microscopy
images of CA1 sections from 6-mo Tg and Wt mice hippocampus. The
sections were labeled with Polβ antibodies (n = 3 for each mouse cat-
egory). The scale bars represent 100 nm. Red arrows point Polβ
localization
Additional file 9 : Figure S9. PCR-based mtDNA damage analysis. (A)
MtDNA damage analysis from 6-mo Wt (n = 5) and Tg (n = 6) mice CA1
region by long range PCR. (B) MtDNA analysis of 12-mo Wt (n = 5) and
Tg (n = 5) mice hippocampi. Data are presented as mean ± SEM. Statistics
were performed with unpaired two-tailed Mann-Whitney test (**P < 0.01)
Additional file 10 : Figure S10. Schematic representation of a coronal
mouse hippocampal section. The dashed red line shows the dissected
CA1 region.
Additional file 11 : Figure S11. Increased cytoplasmic and
mitochondrial accumulation of PolB in neurons from AD brain.
Representative images of frontal cortex sections from human control (Ctr)
and Braak VI Alzheimer (AD) frontal cortex. Immunofluorescence signals
were analyzed by laser scanning confocal microscopy. Nuclei were
detected with DAPI staining. The scale bars represent 20 μm. (A) The
sections were labeled with the tau oligomer antibody, TOC1, and anti-
Polβ antibody (n = 3 for each category) (z projection) or (B) with anti-
bodies against Polβ and VDAC1 (single confocale section).
Additional file 12 : Figure S12. List of oligonucleotides used in mtDNA
analysis and in BER assays.
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